Month: June 2024

GenVivo Announces Initiation of Patient Dosing in a US Phase I/Ib Clinical Trial Evaluating GEN2, a Personalizing, Gene Vector Immunotherapy, in Patients with Advanced Solid Tumors

GEN2’s dose-escalation trial, GVO-1102, will establish the Recommended Phase 2 Dose (RP2D), followed immediately by an expansion phase into 3...

Nkarta Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Announces Pipeline Expansion to Additional Autoimmune Indications

Patient screening underway in Ntrust-1, the first U.S.-based clinical trial of an engineered NK cell therapy for the treatment of...

ANEW MEDICAL Forms Strategic Partnership with Japan’s Okinawa Research Center for Longevity Science (ORCLS) to Study Klotho Gene

Collaboration focuses on research and development of ANEW’s patented Klotho gene therapy in enhancing longevity and reducing age-related diseases ANEW’s...

LabTrace Completes the First Study Using its Blockchain-Based Data Authentication System, Designed to Ensure Data Integrity in Clinical Trials

Parkinson's disease research, sponsored by King's College London, verifies clinical observation data using the Algorand blockchain LONDON, June 27, 2024...

Veterinary Software Market size is set to grow by USD 164.9 million from 2024-2028, Rising pet population to boost the market growth, Technavio

NEW YORK, June 26, 2024 /PRNewswire/ -- The global veterinary software market  size is estimated to grow by USD 164.9 million...

error: Content is protected !!